Affiliation: Wyeth Research
- Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infectionEmily C Lutterloh
Division of Infectious Diseases, Memorial Hospital of Rhode Island, 111 Brewster St, Pawtucket, RI 02860, USA
Crit Care 11:R122. 2007..The receptor for advanced glycation end products (RAGE), a multi-ligand member of the immunoglobulin superfamily, contributes to acute and chronic disease processes, including sepsis...